Home/Filings/4/0001293831-06-000005
4//SEC Filing

Opexa Therapeutics, Inc. 4

Accession 0001293831-06-000005

CIK 0001069308operating

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 3:31 PM ET

Size

11.8 KB

Accession

0001293831-06-000005

Insider Transaction Report

Form 4
Period: 2006-06-15
Transactions
  • Award

    Common Stock Options (right to buy)

    2006-06-15+10,00090,000 total
    Exercise: $5.00Exp: 2011-05-02Common Stock (10,000 underlying)
  • Award

    Common Stock Options (right to buy)

    2006-06-15+65,00080,000 total
    Exercise: $5.00Exp: 2011-05-02Common Stock (65,000 underlying)
Holdings
  • Common Stock Options (right to buy)

    Exercise: $30.00Exp: 2010-01-21Common Stock (5,000 underlying)
    15,000
  • Common Stock Options (right to buy)

    Exercise: $30.00Exp: 2009-04-29Common Stock (10,000 underlying)
    10,000
Footnotes (7)
  • [F1]As adjusted to reflect a one-for-ten reverse stock split of the Issuer's common stock effective June 15, 2006.
  • [F2]21,667 shares of Issuer's common stock shall vest on May 2, 2006, and 43,333 shares shall vest on April 28, 2007.
  • [F3]For services rendered to the Issuer as an executive officer.
  • [F4]10,000 shares of Issuer's common stock shall vest on the date the Issuer's registration statement is deemed effective by the SEC.
  • [F5]Vests in three equal installments on January 21, 2005, January 21, 2006, and January 21, 2007.
  • [F6]Vests in three installments on April 29, 2005, 2006 and 2007.
  • [F7]No new options acquired.

Issuer

Opexa Therapeutics, Inc.

CIK 0001069308

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001069308

Filing Metadata

Form type
4
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 3:31 PM ET
Size
11.8 KB